Cardiff Lexington Corp (CDIX)

[Backstabbed]

what ball

[Zorch305]

They drop the ball with this momentum I'll be pissed

[Backstabbed]

that's also a great option! Just need confirmation form the company!

[Zorch305]

by the volume they might be buying back shares rather than reverse split at this low price

[DD14]

Thank you

[Zorch305]

I think they are trying to uplist

[Backstabbed]

OS too low to be used. Company stated in an 8K that they will use it to uplist only. LET'S BOOM BABY! we are still in trip 6!

[koolmc]

yep the r word need confirmation if they cancelled it or not.

[Zorch305]

it was in an 8k but it may have been cancelled

[DD14]

Anyone have the link with proof of R/S news or is just a roomer?

[Zorch305]

see you later .0006s

[Zorch305]

.0006s going

[Zorch305]

more shares keep adding to bid accumulation man its obvious something is brewing

[Backstabbed]

Let's see a PR!

[Zorch305]

I'd say 16 million in revenues is a lending hand

[Backstabbed]

no doubt! we will fly if company gives us a lending hand!

[Zorch305]

.0005s almost gone

[Zorch305]

we need some news drop it on us CDIX were ready

[Zorch305]

were headed higher watch.....

[Zorch305]

Something definitely brewing awful lot of volume

[Zorch305]

Uplisting like they were talking would be fantastic as well!!.....

[Backstabbed]

Yup! Let's Go!!!!!!!!!

[Zorch305]

That would be the bomb 16 million in revenues and no reverse split would light it off bigtime

[Backstabbed]

that would be sick! Let's Go!

[Zorch305]

I'm hoping they cancel that reverse split

[Backstabbed]

we need a PR! Let's Go!

[Zorch305]

Showing 16 million revs

[Zorch305]

lvl 2s active we are back pink current

[Backstabbed]

start with RS cancellation.

[Zorch305]

Lets hope your right.....interesting last filing whats the money going to be used for?

[Backstabbed]

$CDIX - Back to Pink Current! "Cancel that RS" NEWS and we'll be good at pennies IMO!

[Backstabbed]

Well that sucks! It literally took you a few seconds to tell us how you feel about this company!

Every single runner in the past few weeks have been diluting shares in the $0.002’s! Maybe they let this run first and then dilute for money that they need.

[Pickme2]

Highly doubtful..this toxic financing from acquisitions is never ending…maybe a carrot for the preferred

[Zorch305]

Are they about to pull a rabbit from the hat?

[Zorch305]

very strange vibe today talk of uplist maybe the money is for aquisition lets see if they file the Q long overdue

[flipnrips]

Thompson will take all your money. Be smart here.

[Pickme2]

Maybe CDIX will buy back Nova’s preferred with the proceeds and cancel the RS… highly doubtful… been stuck in this for years.. most likely a complete loss for common shareholders

[Pickme2]

At least Nova’s preferred shares are anti-dilution proof ..so a RS of 1-75,000 won’t affect them..

[Pickme2]

It appears the “Seller” of Nova’s account receivables is CDIX and Nova has to be pissed about there millions of CDIX (expert market 2 times now) shares from being acquired are almost worthless with no market… Very shady

[JMoneyHoops]

I see hopefully the 10-Q isn’t too far behind now

[Zorch305]

I’m not sure they were talking uplisting too maybe it’s an acquisition loan to expand into something new

[Backstabbed]

I don’t understand the logic behind the CEO’s moves. He hasn’t filed the 10Q. We are on grey market.

He filed for a 1 to 75,000 RS

There is no shareholder awareness.

And now makes a move without explaining the motives.

The stock has so much potential. Not sure why they are not doing things the right way

[Zorch305]

Not sure does NOVA need a loan I thought they were profitable

[Backstabbed]

8K out!

[Backstabbed]

On September 29, 2023 Cardiff Lexington Corporation (the “Company”) entered into a Revolving Purchase and Security Agreement (the “Agreement”) with Nova Ortho and Spine, PLLC, a Florida professional limited liability company and the Company’s wholly-owned subsidiary (“Nova”; the Company and Nova are referred to individually as “Seller” and collectively as, “Sellers”), and DML HC Series, LLC Series 308, a Texas limited liability company (the “Purchaser”) for a facility under which Purchaser will, from time to time, buy approved pools of accounts receivables from the Seller with an initial advance of not less than $500,000 and a maximum advance amount of $4,500,000. The Agreement provides the Purchaser’s obligation to advance being subject to its satisfaction of the following conditions in its sole discretion: (i) the aggregate principal amount advanced shall not exceed the then current Availability (as defined in the Agreement) as determined by Purchaser; and (ii) in no event shall any advance or advances attributable to any pool of accounts receivable exceed the advance rate multiplied by the face amount of such pool of accounts receivable. In connection with the purchase of approved pools of accounts receivables, the Seller is obligated to pay to Purchaser certain fees, including a closing fee in the amount of 2% of the maximum advance amount, discount fee in the amount of 2.25% multiplied by the face amount of each pool of purchased account receivables, minimum monthly discount fee in the amount of $3,000, subordinate lien fee in the amount of 5% of the maximum advance amount and certain other fees, expenses, and charges.



Sellers agreed to sell, transfer, assign and otherwise convey to Purchaser as a sale all rights, title and interests of Sellers in and to each pool of accounts receivable accepted by Purchaser for purchase under the Agreement, together with all related rights (but not obligations) of Sellers with respect thereto, including all contract rights, guarantees, letters of credit, liens in favor of Sellers, insurance and other agreements and arrangements of whatever character from time to time supporting or securing payment of all accounts and all right, title and interest of Sellers in any related goods, including Seller’s rights and remedies under Article 2, Part 7 of the UCC.



The Agreement contains customary events of default, including, among others: (a) Seller’s failure to pay any one or more obligations or perform any provision of the Agreement or any other agreement entered into with Purchaser; or any covenant, warranty or representation contained proven to be false in any way; (b) termination, unenforceability or withdrawal of any guaranty or validity guaranty for the Seller’s obligations to Purchaser, or Seller’s failure to perform any of its obligations under such a guaranty or validity guaranty; (c) Seller permits or grants a lien (except permitted liens as set forth in the Agreement) on any of the collateral; (d) suspension of the operation of any Seller’s present business; (e) entry of any judgment against Seller or creation, assertion, or filing of any judgment or tax lien against the Seller’s property, in each case which remains undischarged for 10 days after such entry or filing; (f) transfer of a substantial part (determined by market value) of the Seller’s property; (g) the sale, transfer or exchange of any equity of Nova without first obtaining Purchaser’s written consent; (h) appointment of a receiver for the collateral or for any other property in which any Seller has an interest; (i) seizure of any collateral by any person other than Purchaser; (j) the occurrence of any act, omission, event or circumstance which has or could reasonably be expected to have a materially adverse effect on Sellers; (k) payment by Seller on any subordinated debt in violation of the applicable subordination agreement; and (l) Purchaser, in good faith, deems itself insecure with respect to the prospect of repayment or performance of the Seller’s obligations or any other required performance under the Agreement, subject to any applicable cure period.



Under the Agreement, Seller shall indemnify Purchaser against and save Purchaser harmless from any and all manner of suits, claims, liabilities, demands and expenses, whether directly or indirectly, resulting from or arising out of the Agreement including the transactions or relationships contemplated (including the enforcement of the Agreement), and any failure by Seller to perform or observe its duties under the Agreement.



As collateral security for the payment and performance of all of the Seller’s obligations under the Agreement and related documents, the Seller granted the Purchaser a security interest in all of the assets of the Seller. The security interest granted under the Agreement is senior to any other outstanding liens on the Seller’s assets.



The term of the Agreement is to continue for two years from the date of the Agreement. The Agreement will automatically extend for successive one-year terms from the later of the Agreement date or the date of any executed modification unless the Seller provides at least 30 days but not more than 60 days prior written notice to purchaser of its intention to terminate. Either party may terminate the Agreement by providing at least 60 days prior written notice to the then-effective termination date.



The Agreement contains representations, warranties and covenants by Sellers, including collateral and negative covenants which are customary for transactions of this type.



The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.1 to this report, and which is incorporated herein by reference.

[Backstabbed]

$CDIX - 8K out! Not sure what to take out of it!

[Zorch305]

We could be at a standstill for awhile

[Zorch305]

talk of uplist lets see some revenue results

[Backstabbed]

Waiting on the company to file 10Q - float is less than 400,000,000 here!

[Zorch305]

Anything more here?